Results 81 to 90 of about 86,878 (224)

Leadless Versus Transvenous Dual‐Chamber Pacemakers: Real‐World Evidence From AVEIR DR Coverage With Evidence Development Study

open access: yesJournal of Cardiovascular Electrophysiology, Volume 37, Issue 3, Page 544-553, March 2026.
ABSTRACT Background AVEIR DR, an industry‐first dual‐chamber leadless pacemaker (LP), provides continuous atrioventricular synchrony through implant‐to‐implant (i2i) communication between atrial and ventricular LP devices. It is important to evaluate the early real‐world comparative safety of AVEIR DR LP.
Monica Lo   +10 more
wiley   +1 more source

Complete radiation-free, transthoracic echocardiography-guided, leadless pacemaker implantation

open access: yesEuropean Heart Journal: Case Reports
We described a patient opted for Micra™ leadless pacemaker implantation, which was successfully guided by transthoracic echocardiography (TTE) without use of fluoroscopy during the whole procedure. Chest X-ray on the second day confirmed an appropriate
Wei Hua   +3 more
semanticscholar   +1 more source

Safety Outcomes of Hybrid Open Chest Transvenous Lead Extraction: A Multicenter Experience

open access: yesPacing and Clinical Electrophysiology, Volume 49, Issue 3, Page 247-256, March 2026.
ABSTRACT Background Hybrid open chest transvenous lead extraction (TLE), combining surgical and endovascular techniques, may be utilized in patients requiring concomitant cardiac surgery or with high‐risk features for endovascular extraction. Outcome data in this population remains sparse. Aims To evaluate procedural outcomes and identify predictors of
Nadeev Wijesuriya   +15 more
wiley   +1 more source

A Rare Case of RNRVAS Termination and Re‐Initiation Visualized on a 12‐Lead ECG

open access: yesJournal of Arrhythmia, Volume 42, Issue 1, February 2026.
This case illustrates both termination and re‐initiation of repetitive non‐reentrant ventriculoatrial synchrony (RNRVAS) visualized on a standard 12‐lead ECG. It highlights how pacemaker algorithms such as VIP and PVC response, together with abnormal atrial refractoriness, can trigger or terminate RNRVAS.
Tomoyoshi Morioku   +4 more
wiley   +1 more source

Catheter Ablation and Device Therapy in Patients With Transthyretin Amyloid Cardiomyopathy: A Review of Non‐Pharmacological Therapy

open access: yesJournal of Arrhythmia, Volume 42, Issue 1, February 2026.
Transthyretin amyloid cardiomyopathy (ATTR‐CM) frequently coexists with atrial fibrillation, atrial flutter, and atrial tachycardia as well as occasionally ventricular arrhythmias and often conduction abnormalities, necessitating management for arrhythmias.
Hisanori Kanazawa   +12 more
wiley   +1 more source

Precision patient selection for ablate-and-pace: a multi-center study comparing leadless pacemaker vs. standard pacemaker in patients with indication to ablate-and-pace for atrial fibrillation (LEAD-AP)

open access: yesFrontiers in Cardiovascular Medicine
BackgroundIn patients with symptomatic permanent atrial fibrillation (AF) who are not candidates for rhythm control, atrioventricular node (AVN) ablation followed by ventricular pacing “ablate-and-pace” offers reliable rate control and symptom relief ...
Ingrid Overeinder   +29 more
doaj   +1 more source

Implant Techniques for a Helix-Fixation Dual-Chamber Leadless Pacemaker.

open access: yesHeart Rhythm
Dual-Chamber Leadless Implant Procedure. In a pivotal trial (NCT05252702), the AVEIR™ DR (Abbott) leadless pacemaker system was found to be safe and effective in delivering DDDR synchronous atrial and ventricular pacing.
P. Neužil   +15 more
semanticscholar   +1 more source

Leadless pacemaker implantation in a patient with complex congenital heart disease and limited vascular access

open access: yesIndian Pacing and Electrophysiology Journal, 2016
Management of rhythm related issues might be particularly challenging in patients with congenital heart disease due to complex anatomy and restricted vascular access.
Paolo Ferrero   +4 more
doaj   +1 more source

Dual-chamber leadless pacemaker implant via the RIJ after failed femoral vein implant in a 65-year-old patient with symptomatic bradycardia, with left IJ port and right-sided AV fistula

open access: yesIndian Pacing and Electrophysiology Journal
Introduction: Sinus node dysfunction (SND) is a disorder defined by abnormal initiation and conduction of electrical signals from the sinoatrial node. The preferred first-line treatment for a patient with symptomatic SND is a permanent pacemaker implant.
Shivani Lawa   +3 more
doaj   +1 more source

Leadless Pacemakers

open access: yesJournal of the Royal College of Physicians of Edinburgh, 2019
Benedict M, Wiles, Paul R, Roberts
openaire   +5 more sources

Home - About - Disclaimer - Privacy